BSEM - Company ID 0001658678
The table below shows BIOSTEM TECHNOLOGIES's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 |
|---|---|
| Cash & equivalents | $6.96M |
| Short-term investments | - |
| Receivables | $6.62M |
| Inventory | $4.71M |
| Total current assets | $20.78M |
| Property, plant & equipment | $4.42M |
| Goodwill | $1.53M |
| Total assets | $48.82M |
| Accounts payable | - |
| Total current liabilities | $21.20M |
| Long-term debt | $0.00 |
| Total liabilities | $21.20M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Retained earnings |
| -$38.97M |
| Total equity | $27.61M |